High-dose interferon alfa-2b does not diminish antibody response to GM2 vaccination in patients with resected melanoma: results of the Multicenter Eastern Cooperative Oncology Group Phase II Trial E2696
(Q73567640)
scientific article published on 01 March 2001
scientific article published on 01 March 2001
Language:
other details
description | scientific article published on 01 March 2001 |
External Links
(P356) |
10.1200/JCO.2001.19.5.1430
|
(P698) |
11230488
|